Formulation and Optimization of Bacitracin Zinc Hydrogel Using SodiumAlginate and Carbopol-934

Objective: The objective of this study was to formulate and optimize the validation of Bacitracin Zinc Hydrogel using Sodium Alginate and Carbopol-934 for wound healing. Aim: This primary aim was to formulate and improve a Bacitracin Zinc hydrogel with improved wound healing qualities by utilising carbopol-934 and sodium alginate as gelling agents. The objective of the study was to assess the hydrogel physicochemical characteristics, medication release profile, and healing efficacy, in addition to verifying its performance as a topical wound therapy. objective: Objective : To formulate and and Optimize Validation of Bacitracin Zinc Hydrogel Using Sodium Alginate and Carbopol-934 for wound healing. Materials and Methods: Different amounts of sodium alginate and carbopol-934 were used to formulate the hydrogel. Many formulations were developed, and physicochemical characteristics, such as homogeneity, spreadability, viscosity, and pH, were assessed. Utilising in vitro diffusion tests, the drug release rate was evaluated, and the stability of the hydrogel was examined under various storage conditions. The optimal formulation was determined due to its desired characteristics Results: The optimized formulation, containing an ideal ratio of sodium alginate and Carbopol- 934, exhibited desirable physicochemical properties, including appropriate viscosity, pH, and drug release profile. The in vitro studies showed a sustained drug release over 24 hours. The formulation was found to be stable under ambient conditions for a period of 2 months. Conclusion: The study successfully formulated and optimized a Bacitracin Zinc hydrogel using sodium alginate and Carbopol-934, which showed promising results in terms of drug release, stability, and wound healing efficacy. This hydrogel formulation holds potential for use as a topical treatment for enhanced wound healing.